ACADIA Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

Latest Posts

About This Stock More About This Stock
Stocks Little Changed On July 22 As Risk-On Trade Comes Into Focus
Article By: Michael J. Kramer
Wednesday, July 22, 2020 8:56 AM EDT
Stocks are drifting lower on July 22 as tensions between the US and China are on the front page over the closure of a Chinese consulate in Houston.
In this article: TCEHY, ACAD, AMZN, FCX, JD, SPY Also: IEF, JJC, UDN
Read
Technology Stocks Rip Higher In Buying Frenzy
Article By: Michael J. Kramer
Monday, July 20, 2020 10:55 PM EDT
Stocks rose today, in what was one the strangest rallies I have seen in some time.
In this article: GE, QQQ, NVDA, ACAD, AMZN
Read
Drug Stock Flying To New Highs After Lofty Upgrade
Article By: Schaeffers Research
Tuesday, July 7, 2020 10:13 AM EDT
The shares of Acadia Pharmaceuticals Inc are up 3.4% at $55.50 at last check, so far brushing off the broad-market breather.
In this article: ACAD
Read
This Way Or That…
Article By: Michael J. Kramer
Wednesday, July 1, 2020 8:55 AM EDT
Stocks are moving lower this morning with the S&P 500 futures consolidation around the 3080, but now starting to turn lower along with the rest of the world.
In this article: FDX, ACAD, TSLA, SPY, SPX
Read
Stocks Stage Strong Come Back On June 15, As Bulls Bounce Back
Article By: Michael J. Kramer
Monday, June 15, 2020 10:10 PM EDT
Stocks staged an impressive come back on June 15, after plunging to start the trading session by nearly 2.5%.
In this article: BA, ACAD, SPX, UBER, QQQ
Read

PARTNER HEADLINES

Latest Tweets for $ACAD

No tweets yet!

$ACAD

Key Catalysts For ACADIA Pharmaceuticals
Isaac Pomerance 6/8/2020 3:46:48 AM

What do you think specifically has helped $ACAD thrive during the Pandemic? While they are focusing on the development of drugs unrelated to COVID-19, how were they able to thrive?

Sunday Trio Of Short Ideas
All Things Tech 8/28/2017 3:36:31 AM

100% agreement on $BWLD especially since it has been flat for months in a bullish market with more room to fall.

I disagree with $AMD. If AMD falls below the SMA200, absolutely short, but the Triple Bottom off 12.00 is a cause of concern + a previous ER beat + Q3 ER beat likely & sitting in oversold territory according to (MFI). $SOXX shows a Pennant as well.

$ACAD long-term is down, but short term is up. Above the SMA 20, 50 & 200.

Both AMD & ACAD is big risk little reward in my book unless the Days to Cover is a big enough window. Otherwise just not worth it in my book.

1 to 2 of 2 comments